CN1 A STOCHASTIC ECONOMIC EVALUATION OF LETROZOLE VERSUS TAMOXIFEN AS A FIRST-LINE HORMONAL THERAPY FOR ADVANCED BREAST CANCER IN POSTMENOPAUSAL PATIENTS IN GERMANY
Nov 1, 2002, 00:00 AM
10.1016/S1098-3015(10)61193-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)61193-X/fulltext
Section Title :
Section Order :
1
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61193-X&doi=10.1016/S1098-3015(10)61193-X